Skip to main content
News Archive

TaiRx looks to commercialize therapy targeting drug-resistant cancers – Washington Business Journal

By November 5, 2018May 22nd, 2025No Comments

bhi-tairx-logo

TaiRx, a joint venture between Rockville-based BioHealth Innovation Inc. and Taiwan pharmaceutical company TaiRx Inc., is looking to raise around $5 million.

{iframe}https://www.bizjournals.com/washington/news/2018/10/31/how-maryland-s-newest-company-plans-to-take-down.html{/iframe}

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.